Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) are not appropriate candidates for tirzepatide, as animal studies have shown thyroid tumors with GLP-1 receptor agonists
Using cutting-edge SMGT-GLP-1 technology, the patch delivers active ingredients deep into the skin to regulate insulin, suppress glucagon, and slow gastric emptyingsupporting healthy weight loss
or have possible risk factors for deficiency and need advice on whether testing or GP assessment is the correct next step
Short-term spikes in creatinine happen if you have been vomiting or not drinking
Both medications have shown significant efficacy in promoting weight loss, and with the right support and lifestyle changes, they can be effective tools in managing obesity and improving overall health
A consultation with a provider will help to determine the best procedure for you